Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse events: Liraglutide increases heart rate only in chronic heart failure patients with sinus rhythm and independently of beta-blocker dose

Rasmus Stilling Tougaard*, Anders Jorsal, Lise Tarnow, Nils Henrik Hansson, Caroline Kistorp, Morten Schou, Roni Nielsen, Allan Flyvbjerg, Lars Videbaek, Henning Mølgaard, Jens Cosedis Nielsen, Ida Gustafsson, Henrik Wiggers

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Background. Liraglutide, a glucagon-like peptide-1 agonist, is used for treatment of type 2 diabetes and has beneficial cardiovascular properties. However, treatment increases heart rate (HR) and possibly the risk of cardiovascular events in chronic heart failure (CHF) patients. We investigated potential associations between HR changes and clinical, laboratory and echocardiographic parameters and clinical events in liraglutide treated CHF patients. Methods. This was a sub-study of the LIVE study. CHF patients (N = 241) with a left ventricular ejection fraction ≤45% were randomised to 1.8 mg liraglutide daily or placebo for 24 weeks. Electrocardiograms (N = 117) and readouts from cardiac implanted electronic devices (N = 20) were analysed for HR and arrhythmias. Results. In patients with sinus rhythm (SR), liraglutide increased HR by 8 ± 9 bpm (pulse measurements), 9 ± 9 bpm (ECG measurements) and 9 ± 6 bpm (device readouts) versus placebo (all p<.005). Increases in HR correlated with liraglutide dose (p=.01). HR remained unchanged in patients without SR. Serious cardiac adverse events were not associated with HR changes. Conclusions. During 6 months of treatment, HR increased substantially in CHF patients with SR treated with liraglutide but was not associated with adverse events. The long-term clinical significance of increased HR in liraglutide treated CHF patients needs to be determined.

OriginalsprogEngelsk
TidsskriftScandinavian Cardiovascular Journal
Vol/bind54
Udgave nummer5
Sider (fra-til)294-299
ISSN1401-7431
DOI
StatusUdgivet - okt. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse events: Liraglutide increases heart rate only in chronic heart failure patients with sinus rhythm and independently of beta-blocker dose'. Sammen danner de et unikt fingeraftryk.

Citationsformater